Skip to main content
Fig. 18 | BMC Women's Health

Fig. 18

From: A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer

Fig. 18

Correlation analysis of glutaminase (GLS) expression and tumor heterogeneity and stemness in pan-cancer. (A) Correlation between GLS expression and TMB; (B) Correlation between GLS expression and MSI; (C) Correlation between GLS expression and HRD; (D) Correlation between GLS expression and DNAss; (E) Correlation between GLS expression and RNAss; TMB, tumor mutational burden; MSI, microsatellite instability; HRD, homologous recombination deficiency; DNAss, DNA methylation-based stemness score; RNAss, RNA expression-based stemness score. GLS, glutaminase. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page